China's $850 million pharma investment in Pakistan explained
China's pharma rise could reshape Pakistan's healthcare sector through investment, technology and jobs.
News Desk
The News Desk provides timely and factual coverage of national and international events, with an emphasis on accuracy and clarity.
China is no longer just the world's manufacturing hub. It is rapidly becoming a global pharmaceutical powerhouse, and that transformation could reshape Pakistan's healthcare and pharmaceutical industry.
In this episode of On My Radar with Kamran Khan, Kamran Nasir, CEO of AGP Limited, explains how China built its pharmaceutical sector through research, innovation, and large-scale investment. He also discusses how Pakistan can benefit from the $850 million worth of agreements and MoUs signed at the Pakistan China Pharmaceutical & Healthcare B2B Investment Conference.
The discussion covers local production of pharmaceutical raw materials, vaccine manufacturing, Traditional Chinese Medicine, technology transfer, research collaboration, and whether Chinese investment can reduce medicine prices, cut Pakistan's import bill, strengthen local manufacturing, and position Pakistan as a regional pharmaceutical exporter.
Comments
See what people are discussing